This study investigates the pedigree of 508 individuals over five generations identified by an individual with hypertriglyceridemia, familial hypercholesterolemia, and a lib llpoprotein electrophoretlc phenotype. The sample of 378 living individuals studied extensively for risk factors and disease status was distributed among maternal (170) and paternal (176) 
teins(VLDL), may be either normal (FH lla) or elevated (FH lib). FH patients with the lib phenotype represent a heterogeneous group 2 ' 3 since both environmental and genetic factors may be responsible for the superimposed hypertriglyceridemia. This study was initiated in an attempt to sort out these various influences in a proband with typical FH and the Mb phenotype and to establish the genetic etiology of the plasma lipid levels and lipoprotein patterns in a French-Canadian pedigree identified by such a proband.
This paper presents the description of the study and the initial analyses carried out. We identified 508 individuals in five generations and extensively studied 379 (four generations) who were alive. These individuals were distributed into four major subsets defined with respect to the index: 135 paternal relatives (P subset); 142 maternal relatives (M subset); 26 codescendants (C subset) which included his offspring, his siblings, and all of their offspring; and finally, 75 nonmembers who married into the pedigree (NM subset). The nonmembers were further subdivided according to the subset of the pedigree into which they married (i.e., P nonmembers).
We shall demonstrate in this paper that the adults and children in the different subsets that compose the pedigree differed markedly in the frequencies of lipoprotein abnormalities and clinical manifestations of atherosclerotic disease. It will be shown that the lib phenotype of the index case and the distribution of lipid phenotypes in the different subsets are consistent with the presence of two separate, hereditary lipid disorders in this pedigree that are distinct from familial combined hyperlipidemia. This combination of disorders is associated with an increased frequency of hypercholesterolemia and its clinical manifestations and of cardiovascular morbidity in the C subset.
Methods

Index Case
The index case was selected from 26 potential probands with a type lib electrophoretic phenotype and a well documented diagnosis of xanthomatous FH. The criteria for selection included: the size of the pedigree, the availability of living relatives, the distribution of subjects between maternal and paternal relatives, the number of codescendants, and the geographic dispersion of the individuals of the kindred.
The index case selected (III-7 in figure 1 ) was a French-Canadian police officer, born in Saint-Andre, New Brunswick, who had moved to a Montreal suburb at the age of 18, married at 23, and had seven children. His father was discovered to be hypercholesterolemic shortly before his death at age 57 of a myocardial infarction. This event prompted a family survey which revealed the presence of hypercholesterolemia in several of the index's siblings. Two months before his referral to our lipid clinic at age 36, the presence of hyperlipidemia (cholesterol, 365 mg/ dl; triglycerides, 200 mg/dl) had been documented during hospitalization for atypical chest pain, anxiety, and gastrointestinal symptoms. Myocardial ischemia was indicated by an ECG during a two-step Master's test, and coronary atherosclerosis was demonstrated by a coronary angiogram. Shortly before we began to collect his genealogy in 1972, he sustained (at age 37) an acute anteroseptal myocardial infarction from which he recovered uneventfully.
He was of normal weight (77.6 kg) for his height (1.83 m). Bilateral xanthelasma had been present for several years and were stable in size. He had arcus corneae and xanthomas of the Achilles tendons bilaterally and of the extensor tendon of the middle right finger. His plasma cholesterol level at entry into our clinic in January 1971 was 370 mg/dl and his triglyceride level was 238 mg/dl. The plasma lipopro- tein cholesterol levels were 80 mg/dl for VLDL, 261 mg/dl for LDL, and 29 mg/dl for high density lipoproteins (HDL). He had an impaired glucose tolerance 4 with a normal fasting glycemia of 102 mg/dl and values at 60 minutes of 222 mg/dl and at 120 minutes of 188 mg/dl. The major causes of secondary hyperlipidemias were excluded by a thorough clinical and laboratory evaluation.
III
Definition of the Pedigree
A complete genealogical chart, a description of the clinical variables studied, and the procedures used to sample and record data are available from the National Auxiliary Publications Service (NAPS). The distribution among subsets of the 378 living individuals studied (excluding the index) who spanned four generations and ranged in age from 6 months to 83 years is given in table 1. All the living first-and second-degree relatives of the index and over 75% of the living, more genetically distant relatives of the index were studied. For this study, adults were defined as those individuals who were 20 to 83 years old. All nonmembers were adults. There were 87 persons younger than 20 on the paternal side (49 females), 96 persons on the maternal side (44 females) and 19 persons among the codescendants (8 females). The distribution of the 103 different households among subsets of the pedigree at the time of clinical and biochemical examinations is also given in table 1.
Genealogic records exist for the Acadians and most French-Canadian families. 56 The mother and father of the index case were both descendants from a marriage Which occurred in 1721. The index's paternal grandparents were first cousins and the parents of the Index's maternal grandfather were cousins. Inbreeding coefficients (i.e., the probability that the two alleles at a locus are identical by descent) for the index, his father and his maternal grandfather are 0.000732, 0.0625000, and 0.007812 respectively. No other evidence of consanguinity was identified in this pedigree.
Clinical Evaluation
A systematic clinical evaluation was carried out with four major aims: to measure the levels of known risk factors for healthy and diseased individuals, to record the clinical manifestations of atherosclerosis and of hyperlipidemia, to determine the presence of associated metabolic and cardiovascular diseases, and to assess the major influences on plasma lipid levels. The assessment of atherosclerosis, hypertension, diabetes, obesity and other clinical evaluations were carried out according to criteria that are defined in detail in NAPS.
Sampling Procedure and Laboratory Methods
Blood samples were obtained by venipuncture from an antecubital vein at the time of clinical evalua- tion in the morning after a 12-to 14-hour fast. Blood was collected in tubes which contained either EDTA, citrate, or no anticoagulant. Plasma for lipid and lipoprotein analyses was separated shortly after sampling in a refrigerated centrifuge and kept at 4°C until processing which was carried out within 2 to 4 days in our laboratory. Plasma samples were subjected to preparative ultracentrifugation (d = 1.006 g/ml, 114,000 x g, 16 hours) and dextran sulfate precipitation to derive the cholesterol content of the major plasma lipoprotein fractions according to the method of Hatch and Lees. 7 Paper electrophoresis of plasma lipoproteins was performed in an albumin-containing buffer. 8 Plasma cholesterol was measured in a Technicon Autoanalyzer using the method of Block, et al. 9 Triglyceride concentrations were measured by the method of Laurell 10 adapted for the Autoanalyzer by Kraml and Cosyns. 11 The Autoanalyzer was also used for the determination of plasma glucose 12 and uric acid 13 by standard colorimetric methods. The coefficient of variation for our cholesterol control pool assay (replicate determinations) was less than 3%. The "within-assay" coefficient of variation was also determined from duplicates of 32 samples. This estimate was 3.5% for cholesterol and 4.5% for triglycerides.
Plasma lipid abnormalities were typed following the criteria of Fredrickson et al. 14 with the additional separation of type lla from type Mb according to the triglycerides/total cholesterol (TG/TC) ratio, 2 type lib having a TG/TC ratio of 0.40 or greater. For adults, the cut-off points adopted as the upper limit of normal plasma concentrations were 250 mg/dl for total cholesterol and 150 mg/dl for triglycerides. For children, the guidelines recommended by Kwiterovich 15 were used whereby values above 225 mg/dl for cholesterol and 140 mg/dl for triglycerides are considered abnormal. These initial criteria for normal levels were used to separate affected from normal individuals in a preliminary assessment of the lipoprotein pheno-type, taking into account the clinical setting. This initial classification into normals and hypertipidemics was further documented by plasma lipoprotein analyses. A few adults whose lipid levels were above the cut-off points were later reclassified as unaffected as a result of the lipoprotein analyses. Indeed, in some instances elevated HDL-cholesterol was responsible for the total plasma cholesterol exceeding the upper limit of the normal range. Whenever there was a discrepancy between the plasma lipids and lipoprotein measurements (for instance, normal plasma triglycerides and elevated VLDL-cholesterol) attempts were made to find the source of the discrepancy. In a few instances this led to including some individuals in an "unclassifiable" category.
Urine samples were tested immediately after voiding for the presence of blood, ketones, glucose, and protein using a standard strip test procedure (Labstix, Ames Company, Rexdale, Ontario).
Hypotheses and Statistical Methods
The index was not included in any of the analyses reported here. We considered the distributions of continuous variables and the class frequencies for the categorical variables: 1) in the total sample of individuals, 2) within the subsamples of adults and children in the C, M and P subsets, and 3) in the adults who made up the NM subset. The first general hypothesis tested was that the medians of each continuous variable and relative frequencies of the classes of each categorical variable were similar for adult members and for the nonmembers of the pedigree. Other analyses tested the hypothesis that the class frequencies and the medians were the same: 1) in the P, M and C subsets of adults and children, 2) in the three subsets of spouses who married those members and 3) between hyperlipidemic and normal individuals.
A two-way analysis of frequencies 18 tested the independence of subset assignment and each of the discrete classifications: status of influences, electrophoretic type, presence or absence of clinical manifestations of hyperlipidemia, atherosclerosis, and risk factors. The null hypothesis that two classifications are independent in their effects on the frequency of joint outcomes was tested by the likelihood ratio of the probability of observing the two-way table under the assumption of independence compared to the probability of the observed table.
The null hypothesis that specified subsets have equal medians against the alternative that at least one of the subsets has a different median from at least one other subset was also tested. If the null hypothesis was rejected, multiple a-posteriori comparisons were made to identify statistically significant contrasts. Because these data were not normally distributed and because the variability among individuals was heterogeneous among the subsets compared, we used the nonparametric Kruskal-Wallis test statistic. 17 The tests using these nonparametric statistics are conservative in that the actual level of significance is smaller than the stated level when the variable is normally distributed and there is homoscedasticity among subsets. We chose the nonparametric approach for the interpretation of the data realizing that both parametric and nonparametric approaches assume independence of observations which may be violated when pedigrees are sampled. Unless otherwise noted, the statistical contrasts reported in the results section were considered to be significant when the expected differences would have occurred by chance alone less than 5% of the time. Means, rather than medians, are reported for comparability to other studies.
Results
Among the 378 subjects examined, there were no cases of hypothyroidism, high fever within the week before the examination, nephrosis, active hepatitis, obstructive liver disease, or uncontrolled diabetes mellitus that would have necessitated resampling. Among the 193 women, seven were pregnant, and three of them were resampled at a later date when their normal menstrual cycle had resumed. One was hyperlipidemic but could not be resampled. Her lipid values, as well as those of a child who did not fast, were excluded from the study.
Of the 108 individuals, besides the pregnant women, who presented with one or more influences known to affect lipid levels, none was considered to need resampling. Two persons had major surgery approximately 2 months before sampling but their previously diagnosed hyperlipidemia persisted. One subject had had a partial ileal bypass operation several years earlier for the treatment of hypercholesterolemia but was still hypercholesterolemic. Four subjects were receiving a lipid-lowering agent, but the therapy was not effective. One subject with documented hypercholesterolemia had sustained a recent myocardial infarction within 1.5 months of sampling and still had hypercholesterolemia. Of 34 subjects on a low fat diet, only two reported a recent moderate weight loss, and the influence of this on lipids was considered negligible. There were 19 women on oral contraceptives, 14 on estrogens, and seven had had ovariectomies.
There were no differences between nonmembers and adult members of the pedigree in average age, height, weight, body mass index (BMI = weight over height squared), blood pressure, glucose, and uric acid levels. Furthermore, the mean levels of these measures for adult members and nonmembers were independent of the relationship of the subject to the index. Similarly, when adjustments were made for variations in age, there were no differences between children of the various subsets for the other variables. The large number of children (53.3% of total sample, 101 females and 101 males) accounted for a low mean age of 21.4 years for the total sample at the time of examination.
The distribution of electrophoretic phenotypes of the 349 individuals who were typed is summarized in table 2. Among the 16 individuals not classified as having either a normal or a specific hyperlipidemic type, 14 had a VLDL cholesterol level higher than expected from their total triglyceride level and two had a VLDL cholesterol level lower than expected. These individuals illustrate the difficulty in categorizing subjects using primarily cut-off values. Of the 29 individuals not typed, 26 were children under age 7.
None of the 89 individuals (26%) with hyperlipidemia in this pedigree had a Type I or a Type III electrophoretic pattern. Among nonmembers, the distribution of lipid phenotypes was independent of the subset of the pedigree in which the marriage occurred. However, the high frequency of hyperlipidemia (19 of 73 tested) in the total NM subset was unexpected. Type IV was predominant. For both adults and children, the relative frequencies of lipid phenotypes were significantly different among the P, M, and C subsets (p < 0.001). The highest frequency of hyperlipidemia in both adults and children was observed in the C subset. Only the Type II phenotype was observed. In the P subset, l la was the most frequent type of hyperlipidemia, while IV was most frequent in the M subset.
The adults with Types lla, lib and IV hyperlipidemia were significantly older (6.5 years), heavier (5.1 kg) and had higher blood pressure levels (11 mm Hg systolic and 6 mm Hg diastolic) than those with normal lipid phenotypes (p < 0.01). The four Type V adults were 16 kg heavier on the average than the normal adults and had significantly higher mean uric acid levels (6.3 vs 4.9 mg/dl). On the other hand, the means of age, height, weight, BMI, blood pressure, glucose levels, and uric acid levels were not significantly different in normal and hyperlipidemic children.
The means, standard deviations, and ranges of lipids and lipoproteins are given in table 3 for the nonmembers and the children and adults separately for the three subsets. The mean levels of cholesterol and LDL were significantly higher in adult members compared to nonmembers. There were no significant differences in the levels of lipids and lipoproteins among the various subsets of nonmembers who married into the pedigree.
When all members were considered, the C subset had significantly higher levels for cholesterol, LDL, and the ratios of these with HDL compared to the P and M subsets, even though they had the lowest mean age. The adult members of the C subset had significantly higher levels of all lipids, lipoproteins, and ratios except HDL compared to adult members of the P and M subsets (table 3) . Among the three subsets of children, the C members had significantly higher levels for cholesterol, LDL, cholesterol/HDL and LDL/HDL. While not statistically significant, the mean triglyceride level was approximately 10 mg/dl higher for children in the C subset compared to the P and M subsets. The P subset children had a significantly higher mean for VLDL which could not be accounted for by the higher mean age of children in this subset.
Among normal adults, females had significantly higher mean levels of HDL compared to males (39 vs 34 mg/dl, respectively). Among both adults and children with normal electrophoretic types, there were no statistically significant differences among subsets for any lipid or lipoprotein levels. However, among normal children, those in the C subset had the highest mean levels of cholesterol and triglycerides.
Among adult hyperlipidemics, significant differences were detected between the various subsets of the pedigree. The C subset adult hyperlipidemics had the highest mean levels of cholesterol (357 mg/dl) LDL (268 mg/dl) and cholesterol/HDL (10.3), while the P subset hyperlipidemics had the highest Values are mean ± SD. Range is given in parentheses. VLDL-C = very low density lipoproteln cholesterol; LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol. mean for LDL/HDL (8.0). The hypertipidemic maternal members had mean triglyceride levels 36 mg/dl above the mean for all hyperlipidemic adults (p < 0.001). Among hyperlipidemic children, the ranking of the C, P, and M subset means were similar to that observed for hyperlipidemic adult members.
In summary, these data suggest that the genealogical relationship of members to the index case (i.e., the subset) was not independent of their llpid and lipoprotein levels. While all differences were not statistically significant, all the lipid and lipoprotein levels were highest among C subset members. A similar pattern of elevated levels was seen in both the adults and children of the C subset. Likewise, for both adult members and children, those in the P subset had significantly higher mean cholesterol levels and significantly lower mean triglyceride levels than those in the M subset.
The distribution of lipid and lipoprotein levels among subsets was associated with the percentages of the individuals with major clinical manifestations of hyperiipidemia and atherosclerosis (table 4) . For adults, the members of the pedigree differed significantly from nonmembers only in the percentage of tendon xanthomas (23.8% versus 0%). The distribution of clinical conditions among nonmember adults (table 4) was independent of the subset of the pedigree in which the marriage occurred. Among adults who were members, those in the C subset had significantly higher percentages of arcus comeae, xanthelasma, tendon xanthomas, CHD, and angina pectoris compared to the M and P subsets. For all the manifestations mentioned just above, the P subset members had higher relative frequencies than the M subset members. For children, only the percentages of cigarette and alcohol use varied significantly among subsets. No children in the C subset reported that they smoked and no children in either the P or M subsets reported alcohol use. Although not shown in table 4, hyperlipidemic adults had significantly higher percentages of arcus corneae, xanthelasma, tendon xanthomas, CHD, angina pectoris, Ml, and use of alcohol (25%, 11%, 32%, 29%, 27%, 7%, 25%, respectively) compared to normolipidemic adults (5%, 2%, 0%, 4%, 4%, 1%, 12%, respectively).
Discussion
Typical cases of FH with tendon xanthomas, premature atherosclerosis, and cell surface LDL-receptor deficit may or may not exhibit hypertriglyceridemia. Although FH Ha shares many of the clinical and biological features of FH Mb, some differences be- 18 The issue has been obfuscated by the finding that another distinct heritable disease, familial combined hyperlipidemia, 119 can also harbor the Mb phenotype. The index of the pedigree under study presented all the currently accepted clinical and biochemical criteria of heterozygous FH. 1 We also found that he had the expected partial deficit in LDL-receptors, as measured in surviving lymphocytes by 12S I-LDL degradation. 20 The study reported here was initiated to establish the genetic etiology of hypertriglyceridemia in this individual.
The overall relative frequencies of the Types lla, Mb and IV in adult relatives of the index case in the entire kindred are consistent with the expectation that one-third of the affected relatives would be of each type in familial combined hyperlipidemia. 119 However, there are several reasons to reject the hypothesis that the segregation of these phenotypes in this pedigree is consistent with familial combined hyperlipidemia. First, data from the M and P subsets represent separate lipid disorders that are not typical of familial combined hyperlipidemia. The distribution of electrophoretic phenotypes among the progeny of 33 matings in the P subset (table 5) is explained entirely by familial hypercholesterolemia (FH) determined by a dominant gene at a single locus. A ratio of 14 to 17 (hypercholesterolemic to normal) observed for the progeny of 12 matings in which one parent was hypercholesterolemic does not deviate significantly from the 1 to 1 ratio expected for a trait determined by a dominant gene. In contrast, none of the mating types in the M subset produced hypercholesterolemic progeny (table 5) . The M subset gave a markedly different pattern of lipid phenotypes; only two children had abnormal electrophoretic phenotypes (table 2) . We used an analysis of the continuous variability of lipid levels to test for the presence of a major segregating locus for familial hyperprebetalipoproteinemia (FHPB). Elston et al. 21 suggest four criteria necessary to infer segregation at a major locus. One is that continuously distributed data, when considered as a random sample from some distribution, should fit a mixture of distributions significantly better than they fit a single distribution. The triglyceride values for all members of the M subset and their spouses were standardized for age, sex, and use of hormones using the Lipid Research Clinics population as a standard. 22 Using the method of Day, 23 we found that two normal distributions fit the standardized data significantly better than one. This preliminary finding is consistent with the hypothesis that genetic variability at one locus may contribute to the distribution of triglyceride levels.
A second reason to presume the presence of two heritable disorders in the M and P subsets is provided by a detailed examination of the codescendants (figure 1). If we assume: 1) that the father of the index case transmitted the type Ha phenotype (tendon xanthomas, a high cholesterol level (425 mg/dl), and premature CHD) from the P subset to his offspring; 2) that the mother of the index case transmitted the Type IV phenotype (high triglyceride levels, diabetes, and a milder form of CHD) to her offspring; and 3) that these conditions are determined by two unlinked and nonepistatic heritable disorders, we would expect an equal number of offspring with Type lla hyperlipidemia with tendon xanthomas, Type IV with few clinical signs of hyperlipidemia and atherosclerosis, a mixture of lla and IV (Type Mb with severe disease), and the normal lipid phenotype. Although there was an excess of the Type II phenotype (7 of 8), the types of progeny observed are consistent with the segregation of two separate loci. The normal individual (III-9, figure 1 ) represented the combination of normal genes at the two loci that were transmitted from each of the singly heterozygous parents. The Type lla individuals represented the combination of a mutant gene determining hypercholesterolemia and a normal gene for triglyceride levels from the father and the combination of normal genes at the two loci from the mother. The Type Mb individuals were likely the double heterozygotes for the two mutants, one from the father and one from the mother.
Even more striking than the distribution of electrophoretic phenotypes, were the extreme levels of the lipids and lipoproteins and the high frequency of clinical manifestations and atherosclerotic complications among these eight adults in the C subset who were all under age 40 when examined. Taken in combination with the data from the M and P subsets that support two heritable disorders, these data further support the hypothesis that the adults of the C subset represented the interactions between the effects of a gene determining hypertriglyceridemia and the effects of a gene for hypercholesterolemia. In the next generation in the C subset, one-half the children of the index case had normal triglycerides (three FH lla, one normal) even though the index's spouse had hypertriglyceridemia with a Type IV pattern. Among the nieces and nephews of the index (IV, figure 1 ), Phenotype lla was present in nine of the 10 affected children. Since the mean age at the time of sampling was 9.5 years (No = 18) for this generation, it is probable that the hypertriglyceridemia was not expressed and that this trait perhaps exhibits low penetrance as previously reported in FHPB. 1 It is likely that the hypertriglyceridemia would eventually be expressed in children who had plasma triglycerides in the upper normal range either as Type IV (IV-5, figure 1) or as Type lib (IV-4, the twin of IV-3). It is also possible that the 2-year-old IV-19 with a cholesterol level of 194 might be eventually affected (Type lla).
These interpretations of the distribution of information among the P, M, and C subsets are based on the assumptions that the father of the index who transmitted the hypercholesterolemia was not hypertriglyceridemic, that no secondary causes accounted for the hypertriglyceridemia in the index case, and that the diabetic trait present on the maternal side did not account for a major part of the hypertriglyceridemia in the index. These assumptions are supported by a number of considerations. First, although plasma triglyceride levels for the father of the index (11-1, figure 1 ) were not available, his plasma cholesterol was very high, he had tendon xanthomas, he died at age 57 of a myocardial infarction, and most of his affected biological relatives had the lla phenotype (26 of 33, 79%). Therefore, it is reasonable to assume that he also had FH lla. Second, the index was not obese and he did not consume alcohol or large amounts of simple sugar in his diet at the time of the sampling. Thyroid, liver, and renal functions were normal and he was not taking any drugs or hormones. Third, only three of the 16 hypertriglyceridemic adults in the maternal subset had fasting glucose levels above 115 mg/dl, the level which is regarded by the National Diabetes Group 4 as the limit defining impaired glucose tolerance. Two of these individuals had values below 125 mg/dl and the third (an aunt of the index) was a possible diabetic with a fasting glucose of 158 mg/dl. Because the 59-year-old mother of the index had an adult-onset diabetes requiring insulin, the index case could have inherited the diabetic trait. This is unlikely because his fasting glycemia level was normal. Although he had an abnormal glucose tolerance, his normal fasting blood sugar in the absence of excess body weight was not likely to be the source of hypertriglyceridemia of the magnitude noted after a 12-hour fast.
Indeed, it has been shown that plasma free fatty acids, the substrate for liver synthesis of triglycerides, are not increased in subjects with glucose intolerance unless they are obese. 24 Furthermore, no deficit in plasma or adipose tissue-lipoprotein lipase activity (the major catabolic enzyme for plasma triglycerides) is found in lean individuals until plasma glucose reaches or exceeds 150 mg/dl. 25 This is not to say that glucose intolerance could not contribute to enhancing an inherited defect in triglyceride metabolism or increase the sensitivity of plasma triglyceride levels to dietary carbohydrates. 2627 The high prevalence of abnormal glucose tolerance in patients ascertained for hypertriglyceridemia is well established 28 ' M and was to be expected on the maternal side where FHPB is present. On the other hand, it has been shown that the prevalence of diabetes is the same among normolipidemic and hypertriglyceridemic first-degree relatives of individuals with familial hypertriglyceridemia. 30 This suggests that diabetes and hypertriglyceridemia have separate etiologies, although they may coexist in about 35% of subjects with familial hypertriglyceridemia. 1 1 30 In conclusion, the mild carbohydrate intolerance in the index case may have contributed in part, but not wholly, to his hypertriglyceridemia. There is no way to determine whether it could have contributed to enhancing the severity of the cardiovascular abnormalities in the codescendants by means other than increased plasma triglycerides (i.e., basement membrane changes, effect on collagen metabolism, or other mechanisms).
In conclusion, the distribution of lipoprotein phenotypes, as well as the concentrations of plasma lipids and lipoproteins in the various subsets, corroborates the fact that there is aggregation specifically for hypercholesterolemia (Type II, elevated LDL) on the paternal side and aggregation specifically for hyperprebetalipoproteinemia (Type IV, elevated VLDL) on the maternal side. Adults with hypercholesterolemia in both the P and C subsets have children with elevated cholesterol levels. Matings of normals with hypercholesterolemics in the P subset did not give rise to hypertriglyceridemic children, and matings of normals with hypertriglyceridemics in the M subset did not give rise to hypercholesterolemic children. Finally, the index case had an LDL receptor site deficiency. These observations all suggest that the distribution of phenotypes in this pedigree is not consistent with the criteria currently used to define familial combined hyperlipidemia.
1 ' 19 The nonrandom distribution of lipid and lipoprotein measures and of clinical manifestations among the subsets of this pedigree are more consistent, instead, with a hypothesis that the Mb phenotype in the index resulted from the combined inheritance of FH from the father and FHPB from the mother.
